DK0661985T3 - Peptider, der er i stand til at binde til CTL-prækursere - Google Patents

Peptider, der er i stand til at binde til CTL-prækursere

Info

Publication number
DK0661985T3
DK0661985T3 DK92924245T DK92924245T DK0661985T3 DK 0661985 T3 DK0661985 T3 DK 0661985T3 DK 92924245 T DK92924245 T DK 92924245T DK 92924245 T DK92924245 T DK 92924245T DK 0661985 T3 DK0661985 T3 DK 0661985T3
Authority
DK
Denmark
Prior art keywords
ctl
binding
peptides
peptides capable
seq
Prior art date
Application number
DK92924245T
Other languages
Danish (da)
English (en)
Inventor
Carol Clayberger
Alan M Krensky
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of DK0661985T3 publication Critical patent/DK0661985T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92924245T 1991-11-08 1992-11-03 Peptider, der er i stand til at binde til CTL-prækursere DK0661985T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79192591A 1991-11-08 1991-11-08
PCT/US1992/009440 WO1993008817A1 (en) 1991-11-08 1992-11-03 Cd8 binding domain peptides

Publications (1)

Publication Number Publication Date
DK0661985T3 true DK0661985T3 (da) 2000-01-31

Family

ID=25155235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924245T DK0661985T3 (da) 1991-11-08 1992-11-03 Peptider, der er i stand til at binde til CTL-prækursere

Country Status (11)

Country Link
US (1) US5620956A (de)
EP (1) EP0661985B1 (de)
JP (1) JP3345419B2 (de)
AT (1) ATE181836T1 (de)
AU (1) AU673985B2 (de)
CA (1) CA2122266A1 (de)
DE (1) DE69229562T2 (de)
DK (1) DK0661985T3 (de)
ES (1) ES2136094T3 (de)
GR (1) GR3031169T3 (de)
WO (1) WO1993008817A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025610A1 (en) * 1993-05-05 1994-11-10 Tykocinski Mark L Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule
US6162434A (en) 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
IL132310A0 (en) 1997-04-11 2001-03-19 Sangstat Medical Corp Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
EP1525216A4 (de) 2002-01-24 2009-07-08 Sangstat Medical Corp Kombinationstherapie zur behandlung von hiv-infektion
BRPI0617664B8 (pt) 2005-10-21 2021-05-25 Chugai Pharmaceutical Co Ltd uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
AR057582A1 (es) * 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
CN101495146B (zh) 2006-04-07 2012-10-17 国立大学法人大阪大学 肌肉再生促进剂
GB0609121D0 (en) * 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy
TWI438208B (zh) 2007-01-23 2014-05-21 Chugai Pharmaceutical Co Ltd 抑制慢性排斥反應之藥劑
WO2008139163A1 (en) * 2007-05-09 2008-11-20 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
KR101665729B1 (ko) 2008-06-05 2016-10-12 국립연구개발법인 고쿠리츠간켄큐센터 신경침윤 억제제
US8340782B2 (en) 2009-07-08 2012-12-25 Boston Scientific Neuromodulation Corporation Systems and methods of making and using support elements for elongated members of implantable electric stimulation systems
DK2578231T3 (da) 2010-05-28 2022-12-12 Chugai Pharmaceutical Co Ltd Antitumor-t-celle-reaktionsforstærker
JP6705746B2 (ja) * 2013-12-06 2020-06-03 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 治療用ペプチド
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
KR20200074160A (ko) 2017-10-20 2020-06-24 가꼬우호우징 효고 이카다이가쿠 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물
WO2020250940A1 (ja) * 2019-06-11 2020-12-17 小野薬品工業株式会社 免疫抑制剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365525B1 (de) * 1987-01-30 1995-08-09 The Board Of Trustees Of The Leland Stanford Junior University Lymphocyteninhibierung durch hla-peptide

Also Published As

Publication number Publication date
GR3031169T3 (en) 1999-12-31
JPH07505609A (ja) 1995-06-22
ES2136094T3 (es) 1999-11-16
AU673985B2 (en) 1996-12-05
US5620956A (en) 1997-04-15
WO1993008817A1 (en) 1993-05-13
CA2122266A1 (en) 1993-05-13
DE69229562T2 (de) 1999-11-25
JP3345419B2 (ja) 2002-11-18
EP0661985B1 (de) 1999-07-07
DE69229562D1 (de) 1999-08-12
AU3062892A (en) 1993-06-07
EP0661985A1 (de) 1995-07-12
ATE181836T1 (de) 1999-07-15
EP0661985A4 (de) 1996-07-03

Similar Documents

Publication Publication Date Title
DK0661985T3 (da) Peptider, der er i stand til at binde til CTL-prækursere
HUP0102900A2 (hu) Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok
ES2063350T3 (es) Nuevas proteinas con efecto inhibidor del tnf y su produccion.
RU2001111834A (ru) Композиции и способы WT1-специфичной иммунотерапии
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
EP1283264A3 (de) Interleukin-3 (iL-3) mutanten Polypeptide
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
DE69325178D1 (de) Durch peptidylketon aktivierte inhibitoren, die natürliche und nicht-natürliche peptidsequenzen enthalten
TW215441B (de)
ES473677A1 (es) Procedimiento para la obtencion de ciclopeptidos
IL105347A0 (en) Multiple sclerosis t-cell receptor
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
DE69434137D1 (en) Chaperonin 10
EP0751148A3 (de) D-Aminosäure Substituierungsanaloge von Magaininpeptiden
WO1992017025A3 (en) GnRH analogs
ES2089177T3 (es) Nuevos peptidos inhibidores.
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ES8801308A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
EP1032585A4 (de) Deoxyhypusin reagenz und peptide
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина